Astera Labs, Inc. — Director's Dealing 2024

Mar 22, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-03-20

Reporting Person: Tate Michael Truett (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-20	Common Stock	F	28689	$36	Disposed	1271380	Direct
2024-03-22	Common Stock	C	879108	—	Acquired	2150488	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-22	Series A Preferred	$	C	879108	Disposed		Common Stock (879108)	Indirect

Footnotes

F1: Represents shares of Common Stock withheld by the Issuer in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. Such withholding is mandated by an election of the Issuer made in advance and does not represent a discretionary trade by the Reporting Person.

F2: Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date.

F3: These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.